Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1181-1189

  Ng, Pak C ^a   Li, Karen ^a   Leung, Ting F ^a   Wong, Raymond P O ^a   Li, Geng ^a   Chui, Kit M ^a   Wong, Eric ^a   Cheng, Frankie W T ^a   Fok, Tai F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; HUMAN; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN SEPSIS; NONHUMAN; PREDICTION; PREMATURITY; SCREENING; SENSITIVITY AND SPECIFICITY; SEPTICEMIA; VERY LOW BIRTH WEIGHT;

DISSEMINATED INTRAVASCULAR COAGULATION; DOWN-REGULATION; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-10; INTERLEUKIN-6; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RANTES; SEPSIS; UP-REGULATION;

EID: 33646948510     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.062075     Document Type: Article

References (40)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91.
2. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low birth-weight infants with neonatal infection. JAMA 2004;292:2357-65.
3. Schultz C, Temming P, Bucsky P, Göpel W, Strunk T, Härtal C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004;135:130-6.
4. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71.
5. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecules, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F221-7.
6. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004;89:F229-35.
7. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome. Ann Intern Med 1996;125:690-1.
8. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003;35:535-44.
9. Pinsky MR, Vincent JL, Deviére J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 1993;103:565-75.
10. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
11. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokines production and immune responses. J Immunol 1995;154:5492-9.
12. Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996;87:699-705.
13. Tryzmel J, Miskolci V, Castro-Alcaraz S, Vancurova I, Davidson D. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-κB. Pediatr Res 2003;54:382-6.
14. Luster AD. Chemokine-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
15. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
16. Alam R. Chemokines in the biology of cell movement and inflammation. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. St Louis: Mosby Year Book, 1998:124-36.
17. Ng PC, Li K, Wong RPO, Chui KM, Wong E, Fok TF. Neutrophil CD64 expression: a sensitive diagnostic marker of late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002;51:296-303.
18. Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's prospective. Pediatr Rev 1988;9:219-26.
19. Ng PC, Li K, Wong RPO, Chui KM, Wong E, Li G, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
20. Brieman I, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. New York: Chapman and Hall, 1993:18-55.
21. Sullivan SE, Staba SL, Gersting JA, Hutson AD, Theriaque D, Christensen RD, et al. Circulating concentrations of chemokines in cord blood, neonates, and adults. Pediatr Res 2002;51:653-7.
22. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter, et al. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001;13:234-9.
23. Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 m-RNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60: 2402-8.
24. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60:2835-42.
25. Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995; 86:3841-7.
26. Olszyna DP, Prins JM, Dekkers PEP, De Jonge E, Speelman P, Van Deventer ST, et al. Sequential measurements of chemokines in urosepsis and experimental endotoxemia. J Clin Immunol 1999; 19:399-405.
27. Møller ASW, Bjerre A, Brusletto B, Joø GB, Brandtzaeg P, Kierulf P. Chemokine patterns in meningococcal disease. J Infect Dis 2005;191:768-75.
28. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999; 163:1537-44.
29. Doughty L, Carcillo JA, Kaplan S, Janosky J. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 1998;113-1625-31.
30. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol 2001;22:83-7.
31. Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, De Carolis MP, et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001; 160:345-50.
32. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counter-inflammatory cytokine levels and severity of necrotizing enterocolitis. Pediatrics 1999;103:766-71.
33. Marchant A, Alegre ML, Hakim A, Pierard G, Marecaux G, Friedman G, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995;15:266-73.
34. van Dissel JT, van Langevelde P, Westendorp RGJ, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950-3.
35. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am J Resp Dis 1992;148:427-32.
36. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-80.
37. Ellis M, al-Ramadi B, Hedström U, Frampton C, Alizadeh H, Kristensen J. Significance of the CC chemokines RANTES in patients with haematological malignancy: results from a prospective observational study. Br J Haematol 2005;128:482-9.
38. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD 40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047-54.
39. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NH. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-8.
40. Danese S, de la Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 2004;172:2011-5.